Literature DB >> 20437133

Palliative radiotherapy with 1 x 8 Gy using conformal radiotherapy for chemotherapy-refractory, recurrent, aggressive lymphomas.

Munetaka Matoba1, Kiyotaka Oota, Hisao Tonami, Yasufumi Masaki, Tomouki Sakai, Hisanori Umehara.   

Abstract

We performed palliative radiotherapy with a single-fraction of 8 Gy using a three-dimensional conformal radiotherapy (3D-CRT) technique for patients with dyspnea due to a bulky nasooropharyngeal lesion who had chemotherapy-refractory, recurrent, aggressive lymphoma. After palliative radiotherapy, a complete response with acceptable toxicity was achieved at the irradiated sites of two patients, and the symptoms resolved completely. These results indicated that a single fraction of 8 Gy using 3D-CRT is an effective palliative treatment for chemotherapy-refractory, recurrent, aggressive lymphoma.

Entities:  

Mesh:

Year:  2010        PMID: 20437133     DOI: 10.1007/s11604-009-0400-x

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  9 in total

1.  Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.

Authors:  P Haddad; R K S Wong; G R Pond; F Soban; D Williams; M McLean; W Levin; A Bezjak
Journal:  Clin Oncol (R Coll Radiol)       Date:  2005-09       Impact factor: 4.126

Review 2.  A review of hypofractionated palliative radiotherapy.

Authors:  Stephen T Lutz; Edward L Chow; William F Hartsell; Andre A Konski
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

3.  Effective palliation by low dose local radiotherapy for recurrent and/or chemotherapy refractory non-follicular lymphoma patients.

Authors:  R L M Haas; Ph Poortmans; D de Jong; M Verheij; M van der Hulst; J P de Boer; H Bartelink
Journal:  Eur J Cancer       Date:  2005-08       Impact factor: 9.162

Review 4.  Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.

Authors:  Jackson Sai-Yiu Wu; Rebecca Wong; Mary Johnston; Andrea Bezjak; Timothy Whelan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-03-01       Impact factor: 7.038

5.  Efficacy of palliative low-dose involved-field radiation therapy in advanced lymphoma: a phase II study.

Authors:  Vedang Murthy; Karen Thomas; Kerwyn Foo; David Cunningham; Bernadette Johnson; Andrew Norman; Alan Horwich
Journal:  Clin Lymphoma Myeloma       Date:  2008-08

6.  Limited-stage mantle-cell lymphoma.

Authors:  H A Leitch; R D Gascoyne; M Chhanabhai; N J Voss; R Klasa; J M Connors
Journal:  Ann Oncol       Date:  2003-10       Impact factor: 32.976

7.  Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment--"Hypo Trial".

Authors:  Sandro V Porceddu; Brenda Rosser; Bryan H Burmeister; Mark Jones; Brigid Hickey; Kacy Baumann; Kumar Gogna; Andrew Pullar; Michael Poulsen; Tanya Holt
Journal:  Radiother Oncol       Date:  2007-11-26       Impact factor: 6.280

8.  Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.

Authors:  T P Miller; S Dahlberg; J R Cassady; D J Adelstein; C M Spier; T M Grogan; M LeBlanc; S Carlin; E Chase; R I Fisher
Journal:  N Engl J Med       Date:  1998-07-02       Impact factor: 91.245

9.  High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.

Authors:  R L M Haas; Ph Poortmans; D de Jong; B M P Aleman; L G H Dewit; M Verheij; A A M Hart; M H J van Oers; M van der Hulst; J W Baars; H Bartelink
Journal:  J Clin Oncol       Date:  2003-07-01       Impact factor: 44.544

  9 in total
  1 in total

1.  Low dose palliative radiotherapy for refractory aggressive lymphoma.

Authors:  Osamu Tanaka; Masahiko Oguchi; Takayoshi Iida; Senji Kasahara; Hideko Goto; Takeshi Takahashi
Journal:  Rep Pract Oncol Radiother       Date:  2016-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.